Drugs for HER-2-positive Breast Cancer
Links shared publicly online about this topic.
- 593total visits
Drugs for HER-2-positive Breast Cancer
View full resource at springer.com
Tags: Cancer, Breast Cancer, Drug, Women's Health
Most Recently Shared on January 9, 2011 at 5:21 pm By:
Drugs for HER-2-positive Breast Cancer: series:Milestones in Drug TherapyGrowth factor receptors have long been ... http://bit.ly/fYhvU8
Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application
news-medical.net — “Ventana Medical Systems, Inc., a member of the Roche Group, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the VENTANA Companion Algorithm p53 (DO-7) image analysis application using the VENTANA iScan Coreo Au scanner and VIRTUOSO software.” View full resource at news-medical.net
Most Recently Shared on May 7, 2012 at 1:48 pm By:
Ventana granted FDA clearance for Companion Algorithm p53 (DO-7) image analysis application: Ventana Medical Sys... http://t.co/6MCZ4tuc
Dr. Elaine Schattner: Scientists Identify 10 Molecular Types of Breast Cancer -- How Long Until Progress Reaches the Clinic?
huffingtonpost.com — “If confirmed, the observations in a recent paper could lead to smarter therapy for distinct breast cancer types.” View full resource at huffingtonpost.com
Most Recently Shared on May 4, 2012 at 1:39 am By:
Scientists Identify 10 Molecular Breast Cancer Types - How Long Until Progress Reaches the Clinic? http://t.co/Utmeigix via @huffingtonpost
Darlene Gant, Mom Dying Of Cancer, Inspires Drug Maker To Release Trial Drug Pertuzumab Via YouTube Video
huffingtonpost.com — “When doctors told Tampa Bay, Fla., woman Darlene Gant earlier this year that her breast cancer had returned, they also gave her some good news: The biotech firm Genentech had developed a potentially lifesaving drug called Pertuzumab that was expected to be approved by the FDA in June. But Gant, 46, knew that she might not live that long, so she and her husband decided to record a video pleading for the FDA to approve her use of the drug under the compassionate use clause, which states that patie” View full resource at huffingtonpost.com
Most Recently Shared on May 2, 2012 at 2:56 am By:
Impowerage. Mom to a 1.5 year old who enjoys staying active." /> Dr. Carolyn Anderson Doctor, Surgeon, Ophthalmologist, Physician, and Active Health Library
Dying mom's video convinces drug company to release a drug early to help her. http://t.co/TfBm7bkZ Interesting implications for others
Possible new cancer treatment identified
sciencedaily.com — “New research findings show how it may be possible to render cancer tumors harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. Many of the most common chemotherapy drugs used to treat cancer have serious side effects because they not only affect the cells in the cancer tumor, but also the cells in the rest of the body.” View full resource at sciencedaily.com
Most Recently Shared on April 25, 2012 at 7:32 pm By:
Potential New Cancer Treatment Identified http://t.co/HyPp2pqF
Dying mom's plea for investigational drug is heard. Friends and ABC Action news helps make it happen
abcactionnews.com — “We pride our selves in taking action for our viewers when and how we can. You may have seen a video on Facebook or YouTube about a local mom dying of breast cancer, pleading for a drug not yet approved by the FDA. Darlene Gant contacted me, Linda Hurtado, and together with a group of her very determined friends we got this mom the miracle chance she was praying for.” View full resource at abcactionnews.com
Most Recently Shared on April 23, 2012 at 1:59 am By:
elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist
Woman, 46, w/ met breast cancer video-pleads FDA for drug (Pertuzumab), WashPo: http://t.co/S2pouEf6 -> ABC "action" - http://t.co/Ew9bdsIO
Magnetic Nanochain Detonates Chemo Barrage Inside Breast Tumors
medicalnewstoday.com — “Medicine-toting nanochains slip into tumors and explode a chemotherapy drug into hard-to-reach cores of cancer, engineers and scientists at Case Western Reserve University report.In test” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2012 at 8:05 am By:
Magnetic Nanochain Detonates Chemo Barrage Inside Breast Tumors http://t.co/S5jt0BCM #breastcancer
Eisai breast cancer drug still viewed as not cost effective by NICE - Pharmaceutical and Biotechnology News - Pharma Letter
thepharmaletter.com — “In a third rejection, the UK drug watchdog the National Institute for Health and clinical Excellence (NICE) has issued new guidance not recommending Halaven (eribulin), from Japanese drug major Eisai (TYO: 4523), for the treatment of locally advanced or m” View full resource at thepharmaletter.com
Most Recently Shared on April 3, 2012 at 12:13 pm By:
Even w/discount MT @ThePharmaLetter: NICE still views Eisai breast cancer drug Halaven as not cost effective http://t.co/Bkd28AWx #pharma
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on March 30, 2012 at 7:01 pm By:
PharmaLive Pharma and Health News
#Genentech, #Roche to File BLA for Breast Cancer Drug http://t.co/2WhioI1U #DailyAdvantage
Symposier - Breast cancer research report from San Antonio | Dana-Farber Cancer Institute
symposier.com — “Uploaded and shared in Youtube by: DanaFarberCancerInst — Harold Burstein, MD, PhD, discusses several breast cancer research studies presented at the 2011 San Antonio Breast Cancer Symposium that he thinks are noteworthy but are not likely to generate media coverage, including two aromatase inhibitor studies that found that some women who had chemo-induced menopause did not benefit from the treatment because they regained their menstrual cycle; several studies that looked at the sexual health of” View full resource at symposier.com
Most Recently Shared on March 29, 2012 at 5:59 am By:
Symposier Endocrino Health Site
Drugs targeting new pathways, sexual health of breast cancer PTs, chemo-induced menopause. http://t.co/l2BDjOH9
Potential new therapy that kills cancer cells selectively
news-medical.net — “Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.” View full resource at news-medical.net
Most Recently Shared on March 28, 2012 at 10:15 pm By:
Potential new therapy that kills cancer cells selectively: Researchers have made a drug that helps the immune sy... http://t.co/FFPF2hPs
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer
medicalnewstoday.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantl” View full resource at medicalnewstoday.com
Most Recently Shared on March 27, 2012 at 7:05 am By:
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer: Results ... http://t.co/UZsEDAbO
'Freezing' Secondary Breast Cancer Tumors Shows Promise - Drugs.com MedNews
drugs.com — “In a small and preliminary study, researchers report that they successfully froze secondary tumors in patients with incurable breast cancer. The findings raise” View full resource at drugs.com
Most Recently Shared on March 26, 2012 at 5:10 pm By:
Drugs and Devices OW OW Health
'Freezing' Secondary Breast Cancer Tumors Shows Promise: MONDAY, March 26 -- In a small and preliminary st... http://t.co/odF5Cx6Y #drug
DNA marker predicts platinum drug response in breast, ovarian cancer - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber and Brigham and Women’s researchers have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers might respond to platinum-based chemotherapies.” View full resource at dana-farber.org
Most Recently Shared on March 24, 2012 at 10:30 pm By:
Discovery of genetic marker predicting response to platinum drugs in triple-negative #breastcancer http://t.co/IFMrAlTO
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage - QualityPoint Technologies
qualitypointtech.net — “Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin. These drugs are widely used for ovarian cancer, but as with most cancer drugs, it can be difficult to predict who will respond to therapy. A team of researchers from the Dana-Farber Cancer Institute found that this marker, telomeric allelic imbalance or tAI, could predict sensitivity to therapy in patients with triple-negative breast cancer...” View full resource at qualitypointtech.net
Most Recently Shared on March 24, 2012 at 11:00 am By:
Predicting Response To Platinum Chemotherapy Via Marker Of DNA Damage: Scientists have uncovered a marker of DNA d... http://t.co/yKYetjXu
Non-drug treatments help alleviate symptoms of treatment-induced menopause in breast cancer patients
eurekalert.org — “Researchers from the Netherlands have found that the menopausal symptoms caused by giving chemotherapy or hormonal therapy to younger women with breast cancer can be ameliorated considerably through the use of cognitive behavioral therapy and physical exercise. These interventions can be effective in dealing with such distressing symptoms as hot flushes, night sweats, vaginal dryness, weight gain, urinary incontinence and sexual problems, the researchers say.” View full resource at eurekalert.org
Most Recently Shared on March 24, 2012 at 5:12 am By:
Non-drug treatments help alleviate symptoms of treatment-induced menopause in breast cancer patients: (ECCO-the ... http://t.co/uN1KDcrZ
Advertisement
